BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8790093)

  • 21. Measurement of Goldmann visual fields in older children who received cryotherapy as infants for threshold retinopathy of prematurity.
    Quinn GE; Miller DL; Evans JA; Tasman WE; McNamara JA; Schaffer DB
    Arch Ophthalmol; 1996 Apr; 114(4):425-8. PubMed ID: 8602779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome.
    Ng EY; Connolly BP; McNamara JA; Regillo CD; Vander JF; Tasman W
    Ophthalmology; 2002 May; 109(5):928-34; discussion 935. PubMed ID: 11986099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scleral buckling in stages 4B and 5 retinopathy of prematurity.
    Greven C; Tasman W
    Ophthalmology; 1990 Jun; 97(6):817-20. PubMed ID: 2374687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of acute-phase retinopathy of prematurity on grating acuity development in the very low birth weight infant. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Dobson V; Quinn GE; Summers CG; Saunders RA; Phelps DL; Tung B; Palmer EA
    Invest Ophthalmol Vis Sci; 1994 Dec; 35(13):4236-44. PubMed ID: 8002243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of recognition visual acuity with posterior retinal structure in advanced retinopathy of prematurity.
    Wallace DK; Bremer DL; Good WV; Fellows R; Summers CG; Tung B; Hardy RJ
    Arch Ophthalmol; 2012 Dec; 130(12):1512-6. PubMed ID: 23229690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryotherapy for stage 3+ retinopathy of prematurity: visual and anatomic results.
    Topilow HW; Ackerman AL
    Ophthalmic Surg; 1989 Dec; 20(12):864-71. PubMed ID: 2630967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anatomical and visual results of vitreoretinal surgery for stage 5 retinopathy of prematurity.
    Cusick M; Charles MK; Agrón E; Sangiovanni JP; Ferris FL; Charles S
    Retina; 2006 Sep; 26(7):729-35. PubMed ID: 16963843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Arch Ophthalmol; 1988 Apr; 106(4):471-9. PubMed ID: 2895630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term form identification vision after early, closed, lensectomy-vitrectomy for stage 5 retinopathy of prematurity.
    Mintz-Hittner HA; O'Malley RE; Kretzer FL
    Ophthalmology; 1997 Mar; 104(3):454-9. PubMed ID: 9082272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity.
    Prenner JL; Capone A; Trese MT
    Ophthalmology; 2004 Dec; 111(12):2271-3. PubMed ID: 15582085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Cooperative Group.
    Kivlin JD; Biglan AW; Gordon RA; Dobson V; Hardy RA; Palmer EA; Tung B; Gilbert W; Spencer R; Cheng KP; Buckley E
    Arch Ophthalmol; 1996 Feb; 114(2):150-4. PubMed ID: 8573016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longer-term visual outcome of eyes with retinopathy of prematurity treated with cryotherapy or diode laser.
    O'Keefe M; O'Reilly J; Lanigan B
    Br J Ophthalmol; 1998 Nov; 82(11):1246-8. PubMed ID: 9924326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial.
    Quinn GE; Dobson V; Siatkowski R; Hardy RJ; Kivlin J; Palmer EA; Phelps DL; Repka MX; Summers CG; Tung B; Chan W;
    Ophthalmology; 2001 Feb; 108(2):343-7. PubMed ID: 11158812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial.
    Good WV;
    Trans Am Ophthalmol Soc; 2004; 102():233-48; discussion 248-50. PubMed ID: 15747762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk analysis of prethreshold retinopathy of prematurity.
    Hardy RJ; Palmer EA; Dobson V; Summers CG; Phelps DL; Quinn GE; Good WV; Tung B;
    Arch Ophthalmol; 2003 Dec; 121(12):1697-701. PubMed ID: 14662587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interobserver agreement for grating acuity and letter acuity assessment in 1- to 5.5-year-olds with severe retinopathy of prematurity.
    Harvey EM; Dobson V; Tung B; Quinn GE; Hardy RJ
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1565-76. PubMed ID: 10359339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of low vision in advanced cicatricial retinopathy of prematurity.
    Droste PJ; Trese MT
    J Pediatr Ophthalmol Strabismus; 1995; 32(3):188-90. PubMed ID: 7636701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of cryotherapy for retinopathy of prematurity.
    Algvere P
    Acta Ophthalmol Suppl (1985); 1993; (210):72-4. PubMed ID: 8329961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual outcomes after early vitreous surgery for aggressive posterior retinopathy of prematurity.
    Azuma N; Ito M; Yokoi T; Nakayama Y; Nishina S
    JAMA Ophthalmol; 2013 Oct; 131(10):1309-13. PubMed ID: 23990065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.